Should Pregabalin Be Used in the Management of Chronic Neuropathic Pain in Adults? A Cochrane Review Summary With Commentary

Carlotte Kiekens^{1

2}

Affiliations

¹ Department of Physical and Rehabilitation Medicine, University Hospitals Leuven, Leuven, Belgium.
² Department of Development and Regeneration, KU Leuven - University of Leuven, Leuven, Belgium.

Comment

Carlotte Kiekens. PM R. 2019 Dec.

. 2019 Dec;11(12):1360-1363.

doi: 10.1002/pmrj.12283.

Carlotte Kiekens^{1

2}

¹ Department of Physical and Rehabilitation Medicine, University Hospitals Leuven, Leuven, Belgium.
² Department of Development and Regeneration, KU Leuven - University of Leuven, Leuven, Belgium.

No abstract available

Comment on

Pregabalin for neuropathic pain in adults.
Derry S, Bell RF, Straube S, Wiffen PJ, Aldington D, Moore RA. Derry S, et al. Cochrane Database Syst Rev. 2019 Jan 23;1(1):CD007076. doi: 10.1002/14651858.CD007076.pub3. Cochrane Database Syst Rev. 2019. PMID: 30673120 Free PMC article.

1. Derry S, Bell RF, Straube S, Wiffen PJ, Aldington D, Moore RA. Pregabalin for neuropathic pain in adults. Cochrane Database Syst Rev. 2019;1:CD007076. https://doi.org/10.1002/14651858.CD007076.pub3.
1. Finnerup NB, Haroutounian S, Kamerman P, et al. Neuropathic pain: an updated grading system for research and clinical practice. Pain. 2016;157:1599-1606.
1. Colloca L, Ludman T, Bouhassira D, et al. Neuropathic pain. Nat Rev Dis Primers. 2017;3:17002.
1. Scholz J, Finnerup NB, Attal N, et al. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain. 2019;160:53-59.
1. van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014;155:654-662. Erratum in: Pain. 2014;155(9):1907.